ELITE PHARMACEUTICALS INC /NV/ bought ELTP

August 25, 2025 · Form 4 insider transaction

ELITE PHARMACEUTICALS INC /NV/ bought 2,500,000 shares of Elite Pharmaceuticals, Inc. at $0.03 per share, a transaction worth $75.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction

Acquired (buy-side)

2,500,000

Price

$0.03

Total value

$75.0K

InsiderELITE PHARMACEUTICALS INC /NV/

Role—

CompanyElite Pharmaceuticals, Inc. (ELTP)

SecurityCommon Stock

Transaction codeM: Option exercise

Transaction dateAugust 25, 2025

Filing dateAugust 26, 2025

Shares owned after4,300,000

OwnershipDirect

10b5-1 planNo

AmendedNo

View the original Form 4 on SEC EDGAR